Virtu Financial’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Virtu Financial’s Portfolio COEPW Stock Details COEPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-23,010	Closed	–	–	1722
2025 Q4	$0	Buy	+23,010	New	+$403	﹤0.01%	1756
2023 Q1	–	Sell	-20,693	Closed	-$2K	–	1598
2022 Q4	$2K	Buy	+20,693	New	+$1.38K	﹤0.01%	1479
2022 Q2	–	Sell	-18,566	Closed	-$2K	–	1646
2022 Q1	$2K	Buy	18,566 +2,594	+16%	+$417	﹤0.01%	1423
2021 Q4	$5K	Buy	+15,972	New	+$5.32K	﹤0.01%	1611
2021 Q2	–	Sell	-10,761	Closed	-$5K	–	1584
2021 Q1	$5K	Buy	+10,761	New	+$10.1K	﹤0.01%	1533

Other funds holding COEPW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

HHGC

Hunting Hill Global Capital New York $129M AUM 17.34% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Virtu Financial's COEPW Position: Q1 2026 in Review

Virtu Financial sold out of Coeptis Therapeutics Warrants (COEPW) in Q1 2026, closing a stake of 23,010 shares.

Virtu Financial first reported a position in COEPW in Q1 2021 and held it in 5 quarters. The position peaked at $5K in Q4 2021. 10 funds tracked by Wall St. Rank hold COEPW as of Q1 2026.

Virtu Financial reported no remaining Coeptis Therapeutics Warrants position as of Q1 2026 after selling out during the quarter.
Virtu Financial sold 23,010 Coeptis Therapeutics Warrants shares in Q1 2026.
Virtu Financial first reported a position in Coeptis Therapeutics Warrants in Q1 2021 and held it in 5 quarters.
Virtu Financial's Coeptis Therapeutics Warrants position peaked at $5K in Q4 2021.
10 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.